Ulcerative colitis trials in Puerto Rico
4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- San Juan
- Age
- 18 years to 70 years
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - Phase 2Taking peopleLY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Where
- San Juan
- Age
- 18 years to 80 years
- People
- 1,431 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07415044 - Phase 3Taking peopleAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Dorado, Vega Baja
- Age
- 16 years to 80 years
- People
- 980 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184996 - Phase 2/3Taking peopleA Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Where
- San Juan
- Age
- 2 years to 17 years
- People
- 120 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05076175